RxDoctor Payments Data

Nidfel Herrera, PA

Physician Assistant · Valencia, CANPI 1295993442

Payments from drug & device makers

$461in general payments, 2019–2025

Across 19 payments — averaging $24.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$79
  • Amgen$51
  • Pfizer$50
  • Novo Nordisk$44
  • GSK$42
  • AbbVie$38
  • plus $158 from 6 others

What the payments were for

  • Food & beverage$461100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$461 in reported general payments places this provider in the 60th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$72,714
Medicare patients
472
Services billed
1,998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Repatha SureclickEvolocumab22$33,857
OzempicSemaglutide30$31,453
WegovySemaglutide14$22,428
MounjaroTirzepatide12$12,770
KerendiaFinerenone11$11,143
Albuterol Sulfate HfaAlbuterol Sulfate36$879
Ezetimibe17$755
Doxycycline Hyclate53$399
Rosuvastatin Calcium42$395
Trazodone Hcl36$380
Levothyroxine Sodium43$355
Amlodipine Besylate25$325
Calcitriol29$319
Atorvastatin Calcium57$317
Losartan Potassium16$312

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$44$53,88244 claims
Lilly USA, LLCMounjaro$21$12,77012 claims
BayerKerendia$28$11,14311 claims
PfizerPaxlovid$50$012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Valencia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →